| P50 | author | Hong Liao | Q90946968 |
| | Shanling Liu | Q90946971 |
| P2093 | author name string | He Wang | |
| | Hang Su | |
| | Zhenjun Liu | |
| P2860 | cites work | Transformation of Lactobacillus by electroporation | Q71722175 |
| | Histological and histochemical uses of periodic acid | Q82362479 |
| | Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health | Q21129223 |
| | Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine | Q26746324 |
| | IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans | Q26799351 |
| | Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents | Q26863344 |
| | Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy | Q27010562 |
| | Crystal structure of the WOPR-DNA complex and implications for Wor1 function in white-opaque switching of Candida albicans | Q27684934 |
| | Treatment of vulvovaginal candidiasis: a review of the literature | Q28084571 |
| | Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications | Q28087327 |
| | Defensins: antimicrobial peptides of innate immunity | Q28204453 |
| | Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice | Q30952009 |
| | Candida infections of the genitourinary tract | Q33825621 |
| | Th17 cells and IL-17 in protective immunity to vaginal candidiasis. | Q33983438 |
| | Vaginal discharge--causes, diagnosis, and treatment | Q34363598 |
| | Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORγt and dectin-2. | Q34393801 |
| | Frequent detection of 'azole' resistant Candida species among late presenting AIDS patients in northwest Ethiopia | Q34582330 |
| | Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. | Q34936576 |
| | Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination | Q35530213 |
| | Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice | Q35650359 |
| | Evaluation of vaginal complaints | Q35693721 |
| | Protocols for vaginal inoculation and sample collection in the experimental mouse model of Candida vaginitis | Q36015132 |
| | Adaptive immune responses to Candida albicans infection | Q36147114 |
| | Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties | Q36302360 |
| | Candida albicans pathogenicity mechanisms. | Q36845868 |
| | Unifying themes in host defence effector polypeptides | Q36912131 |
| | Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis | Q37106755 |
| | Vaginal lactobacilli as potential probiotics against Candida SPP. | Q37159489 |
| | The Antifungal Activity of Lactoferrin and Its Derived Peptides: Mechanisms of Action and Synergy with Drugs against Fungal Pathogens | Q37590545 |
| | An insight into the antifungal pipeline: selected new molecules and beyond. | Q37781273 |
| | Yeast ATP-binding cassette transporters conferring multidrug resistance | Q38019037 |
| | Novel antifungal agents: a patent review (2011 - present). | Q38176048 |
| | Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery | Q38185803 |
| | Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospects | Q38232781 |
| | The role of lactic acid production by probiotic Lactobacillus species in vaginal health | Q39257593 |
| | Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections | Q39318147 |
| | Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076. | Q40296898 |
| | Selection of Lactobacillus strains as potential probiotics for vaginitis treatment | Q40684314 |
| | Probiotic Lactobacillus strains protect against myelosuppression and immunosuppression in cyclophosphamide-treated mice | Q42208385 |
| | Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects. | Q42209674 |
| | Zeamatin, clotrimazole and nikkomycin Z in therapy of a Candida vaginitis model | Q44121033 |
| | Probiotic Lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract | Q44481793 |
| | Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial | Q45168991 |
| | Vaginal colonization and activity of the probiotic bacterium Lactobacillus fermentum L23 in a murine model of vaginal tract infection | Q45793860 |
| | Construction of recombinant Lactobacillus casei efficiently surface displayed and secreted porcine parvovirus VP2 protein and comparison of the immune responses induced by oral immunization | Q46885202 |
| | Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence. | Q47564420 |
| | The Role of IL-17 in Protection against Mucosal Candida Infections | Q49184561 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lacticaseibacillus casei | Q139777 |
| | candidiasis | Q273510 |
| | vulvovaginal candidiasis | Q977090 |
| | probiotics | Q1816730 |
| | murine model | Q122890741 |
| P304 | page(s) | 7 | |
| P577 | publication date | 2019-01-08 | |
| P1433 | published in | BMC Microbiology | Q15759430 |
| P1476 | title | Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis | |
| P478 | volume | 19 | |